Time to Invest in L...
Health Care: Drugs
Mylan Inc (MYL: NASDAQ)
$31.18 -0.58 | -1.81%
05/24/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with MYL
- Portfolio NameUser Type
- ProJohn Paulson
- ContributorRocket Stocks for the Week ...
- ContributorPharmaceutical Short Squeez...
- UserPerpetual growers
- ProD.E. Shaw
- Contributor8 Pharma Stocks to Watch
- ContributorRocket Stocks for the Week ...
- UserLA
- Contributor12 'Conviction Buys' on Gol...
- UserWatch List - Healthcare / B...
Latest MYL Headlines from TheStreet
- Mylan Becomes #17 Most Shorted Nasdaq 100 Component, Replacing Akamai Technologies 05.10.13 | 03:05 pm
- 20 S&P500 Stocks Reporting Earnings This Week With History Of Upside 04.29.13 | 01:04 pm
- Merz Withdrawal Frees Obagi-Valeant Merger 04.09.13 | 01:04 pm
- Analysts' Actions: BTU JAZZ MYL SKUL TDG 03.11.13 | 08:03 am
- 5 Rocket Stocks to Buy Before the World Ends 12.17.12 | 10:12 am
- Paulson & Co Third Quarter Stock Holding 11.30.12 | 01:11 pm
- Analysts' Actions: AEO CIT GPS JBLU GME 11.16.12 | 08:11 am
- Boring Is Beautiful 10.02.12 | 06:10 am
- Buy the 5 Pharma Stocks Everyone Hates 08.07.12 | 11:08 am
- Mylan Management Discusses Q2 2012 Results - Earnings Call Transcript 07.26.12 | 03:07 pm
Press Releases for MYL
- Mylan Schedules First Quarter 2013 Financial Results Conference Call And Live Webcast - PR Newswire 04.09.13 | 08:04 am
- Mylan Launches First Generic Version Of Zovirax® Ointment - PR Newswire 04.03.13 | 03:04 pm
- Mylan Launches Generic Version Of Xopenex® Inhalation Solution - PR Newswire 03.18.13 | 11:03 am
- Mylan Announces Fortamet® Settlement Agreement - PR Newswire 03.13.13 | 03:03 pm
- Mylan Files Annual Report On Form 10-K For Year Ended Dec. 31, 2012 - PR Newswire 03.04.13 | 04:03 pm
- Mylan To Acquire Agila To Create Leading Global Injectables Platform - PR Newswire 02.27.13 | 04:02 pm
- Mylan Launches Generic Antara® Capsules - PR Newswire 02.25.13 | 08:02 am
- Mylan Launches Innovative Portfolio Of Antiretroviral Products For Treatment Of HIV/AIDS In South Africa - PR Newswire 02.23.13 | 11:02 am
- Thousands Of Schools Nationwide Are Receiving Free EpiPen(R) (epinephrine) Auto-Injectors Through The Mylan Specialty L.P. EpiPen4Schools(TM) Program - PR Newswire 02.20.13 | 09:02 am
- Mylan Enhances Partnership With Biocon Through Strategic Collaboration For Insulin Products - PR Newswire 02.13.13 | 04:02 pm
Partner Headlines for MYL
- Favorable Verdict for Mylan - Analyst Blog - Zacks 05.23.13 | 12:05 am
- Merck Enters into Strategic Deal - Analyst Blog - Zacks 05.23.13 | 12:05 am
- Actavis, Warner Chilcott Stocks Rise On Merger News - Investor's Business Daily 05.20.13 | 06:05 pm
- Actavis to acquire Warner Chilcott in $5bn pharmaceutical deal - Financial Times 05.20.13 | 03:05 pm
- Futures Steer Sharply Higher; IBD 50 Stock Mylan Spikes - Investor's Business Daily 03.06.13 | 08:03 am
- Stocks At Highs, Retain Gains; Alaska Air Hits High - Investor's Business Daily 03.05.13 | 03:03 pm
- Market Close Report: NASDAQ Composite index closes at 3,160.19 down -2.07 points - NASDAQ 02.28.13 | 09:02 pm
- Stocks Strengthen For Solid Feb. Gains; Not Catamaran - Investor's Business Daily 02.28.13 | 03:02 pm
- Stocks Open Down, Turn Mixed; Mylan, Monster Beverage Gap Up - Investor's Business Daily 02.28.13 | 10:02 am
- 3 Industries Set To Profit From An Aging Population - Seeking Alpha 01.31.13 | 09:01 am
